PREVIEW

Shingles Vaccine May Slow Progression Of Dementia, New Study Suggests. Research published in Cell this week shows that the two-dose vaccine, recommended for adults over 50 may not only protect against shingles but could also slow the progression of dementia. The study, led by Dr. Pascal Geldsetzer at Stanford University, found that the vaccine may offer therapeutic benefits for those already suffering from dementia, reducing the risk of dying from the disease. While shingles is known to cause complications in older adults, recent findings indicate that the vaccine’s protective effect could extend to neurodegenerative diseases, potentially offering a new approach to dementia treatment. With the shingles vaccine proving to be more than 90% effective at preventing the illness this emerging research is fueling excitement as it suggests a possible new tool in the fight against dementia. The findings were described as both unexpected and exciting by the study’s senior author.
Instructions: THIS VIDEO MUST NOT BE EDITED FOR LENGTH TO COMBINE WITH OTHER CONTENT